top of page
Search


2ndAP Offers a Processing Path for RUO Peptide Businesses
2ndAP helps eligible U.S. and Canadian research-use-only peptide businesses explore a transparent, partner-supported path to card processing. The program includes ongoing website compliance monitoring, preset terms, and separate underwriting review; meeting compliance requirements does not guarantee approval.
Thomas M Troyer
Sep 253 min read


Online shopping may be entering a new phase
Mastercard is moving AI-assisted shopping from an industry concept toward real payment activity through Alchemy AgentCard. Here is what ecommerce and high-risk merchants should understand about authorization, fraud, disputes and operational readiness.
Thomas M Troyer
Sep 175 min read


Mastercard’s Specialty Merchant Fees Are a Pure Money Grab
Mastercard has added transaction and volume fees for businesses classified as specialty merchants. In 2ndAP’s view, this is a pure money grab: the published guidance identifies new charges, but no new merchant-facing fraud-prevention service or measurable protection purchased by those fees.
Thomas Troyer
Sep 75 min read


Eli Lilly’s Peptide Power Grab: When Patent Protection Becomes Market Control
Eli Lilly’s tirzepatide patent should not become a blanket ban on peptide processing. We examine Visa’s penalties, corporate pressure, and the growing threat of financial deplatforming.
Thomas Troyer
Sep 46 min read
bottom of page
